Immatics N.V. (IMTX)
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.
Address
PAUL EHRLICH-STRASSE 15
TUBINGEN, 2M 72076
Founded
2020
Number of Employees
343
Website
http://www.immatics.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)